MK
Manju Krishna
About Manju Krishna
Data last updated:
Manju Krishna is a Director at Kestrel Pharmaceuticals Private Limited (since 2019). The company operates in Chemicals. Kestrel Pharmaceuticals Private Limited reported revenue of ₹13.1 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Kestrel Pharmaceuticals Private Limited U24239KL2018PTC055732 | Director | 12 Mar 2019 | 2018 | ₹13.1 Lakh (FY 2025) | Active |
Board colleagues of Manju Krishna
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abhilash Thankappan | 08587537 | Kestrel Pharmaceuticals Private Limited | Director |
| Nisha Prajeesh | 08706117 | Kestrel Pharmaceuticals Private Limited | Director |
| Priyesh Thena Parambil | 08290766 | Kestrel Pharmaceuticals Private Limited | Managing Director |
| Vysakh Santhoshkumar Nair | 08290767 | Kestrel Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manju Krishna
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manju Krishna
Manju Krishna currently holds 1 directorship: Kestrel Pharmaceuticals Private Limited (Director, since 12 Mar 2019, revenue ₹13.1 Lakh (FY 2025)).
Manju Krishna was first appointed on 12 Mar 2019 as Director at Kestrel Pharmaceuticals Private Limited.
The current boards of Manju Krishna's companies include Abhilash Thankappan (Kestrel Pharmaceuticals Private Limited), Nisha Prajeesh (Kestrel Pharmaceuticals Private Limited), Priyesh Thena Parambil (Kestrel Pharmaceuticals Private Limited), Vysakh Santhoshkumar Nair (Kestrel Pharmaceuticals Private Limited).